PEPSICO, INC for PEPSICO INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2012 | $630,075 | Replaced |
| 2nd Quarter - Amendment (this page) | Apr 11, 2013 | $630,000 | Replaced |
| 2nd Quarter - Amendment | Jul 22, 2013 | $930,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relative to noncommunicable diseases, generally; health and wellness and obesity prevention, generally (no specific legislation); grant program administration, generally, and under the Dep't of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH AVERY | — |
| KIMBERLY BETZ New | Office of National Drug Control Policy |
| PAUL BOYKAS | — |
| JULIA-FELIZ UMALI SESSOMS | — |
Consumer Issues/Safety/Products CSP
Provisions relating to protecting consumer privacy and data security issues, digital privacy cyber-security, data breach notification, e-commerce, geo-location technology, mobile privacy, data collection of consumers personal information, childrens privacy, advertising & marketing to kids contained in: S. 1152, Personal Data Privacy and Security Act; S. 1535, Personal Data and Breach Accountability Act of 2011;H.R. 611, Building Effective Strategies to Promote Responsibility Accountability Choice Transparency Innvovation Consumer Expectations and Safeguards Act (Best Practices Act); H.R. 654, Do Not Track Me Online Act; H.R. 1528, Consumer Privacy Protection Act of 2011; H.R. 2577, Safe Data Act; S. 799 Commercial Privacy Bill of Rights Act of 2011; and, the Administration's regulatory actions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIA-FELIZ UMALI SESSOMS | — |
Taxation/Internal Revenue Code TAX
International and domestic corporate tax reform (generally, no specific legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH AVERY | — |
| DIEGO TOMAS RUIZ | — |
Trade (domestic/foreign) TRD
S. 3285, re: the extension of nondiscriminatory treatment (normal trade relations treatment) to products of the Russian Federation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH AVERY | — |
| KIMBERLY BETZ New | Office of National Drug Control Policy |
| DIEGO TOMAS RUIZ | — |
Financial Institutions/Investments/Securities FIN
Corporate governance issues generally, no specific legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIEGO TOMAS RUIZ | — |
Agriculture AGR
Childhood obesity (generally, no specific legislation); restrictions on use of Supplemental Nutrition Assistance Program (no specific legislation); implementation of S. 3307-Healthy, Hunger-Free Kids Act of 2010, provision relating to competitive foods in schools; HR 2779 - To exempt inter-affiliate swaps from certain regulatory requirements put in place by the Dodd-Frank Wall Street Reform and Consumer Protection Act;HR 2682, "Business Risk Mitigation and Price Stabilization Act of 2012" re: margin requirements on non-financial end-users; and proposals to reauthorize the 2008 Farm Bill, particularly provisions relating to commodity and nutrition. H.R. 4351, Lets Grow Act of 2012 re: assistance for sustainable agriculture and improved access to nutrition in American cities. H.R. 3848, "Protecting Foods and Beverages from Government Attack Act re: use of federal money against foods and beverages. S. 3240, "The Agriculture Reform, Food and Jobs Act of 2012"; provisions relating to genetically modified organisms; limitations on funding or use of supplemental nutrition assistance; sugar price support program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH AVERY | — |
| KIMBERLY BETZ New | Office of National Drug Control Policy |
| PAUL BOYKAS | — |
| DIEGO TOMAS RUIZ | — |
| JULIA-FELIZ UMALI SESSOMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.